Zobrazeno 1 - 10
of 31
pro vyhledávání: '"B A, BOURONCLE"'
Publikováno v:
Blood. 84(12)
Twenty-four patients with advanced hairy cell leukemia treated with 2'-deoxycoformycin (dCF) were studied after achieving complete remission to determine the impact of treatment on survival, disease-free survival, long-term complications of treatment
Autor:
B A, Bouroncle
Publikováno v:
Leukemialymphoma. 14
Since 1958, when HCL was first recognized as a new clinical, hematologic and pathological entity, great progress has been made through the contributions of numerous investigators: The hematopathology of the hairy cell and the organs involved by the d
Autor:
Michael K. Samson, Ronald L. Stephens, Brent A. Blumenstein, Antoinette J. Wozniak, N T Shah, Ronald B. Natale, B A Bouroncle, E D Crawford, S J Altman, C D Ford
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 9(1)
This is a Southwest Oncology Group (SWOG) prospective randomized trial of cisplatin, vinblastine, and bleomycin (PVB) versus vinblastine, cisplatin, and etoposide (VP-16) (VPV) in the treatment of advanced germ cell tumors of the testis. The study ob
Autor:
B A, Bouroncle
Publikováno v:
Blood. 53:412-436
Publikováno v:
Blood. 68:1119-1122
Ten patients with progressive hairy cell leukemia were treated with 2′deoxycoformycin (dCF) by intravenous bolus (4 mg/m2) given every other week. All ten patients are evaluable for response and nine of the ten patients have achieved a complete rem
Autor:
B. A. Bouroncle
Publikováno v:
JAMA: The Journal of the American Medical Association. 207:2049-2052
Autor:
B A, Bouroncle
Publikováno v:
Seminars in oncology. 11(4 Suppl 2)
Autor:
B A, Bouroncle
Publikováno v:
Leukemia. 1(4)
In a series of 116 patients with hairy cell leukemia at the Ohio State University, followed for over 20 years, several unusual presentations and complications were encountered. The awareness of these unusual findings might be of help to investigators
Publikováno v:
Leukemia. 1(4)
Twelve evaluable patients with progressive hairy cell leukemia were treated with deoxycoformycin at a dose of 4 mg/m2 every 2 weeks. Five patients had not been splenectomized, and one had failed to respond to interferon-alpha. Complete remission, as
Publikováno v:
Journal of the National Cancer Institute. 44(5)